A study investigated the safety of nephrectomy after exposure to HIF-2α antagonists for localized VHL-deficient kidney cancer.
Stage 2 kidney cancer involves a tumor over 7 cm, confined to the kidney, often treated surgically. Diagnosis includes imaging, blood tests, and possibly biopsy to confirm cancer type and stage.